{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:40:23Z","timestamp":1793932823896,"version":"4.8.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.preteyeres.2010.03.001","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T04:35:13Z","timestamp":1268886913000},"page":"312-334","source":"Crossref","is-referenced-by-count":919,"title":["Preservatives in eyedrops: The good, the bad and the ugly"],"prefix":"10.1016","volume":"29","author":[{"given":"Christophe","family":"Baudouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Brignole-Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.preteyeres.2010.03.001_bib1","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0039-6257(97)80016-1","article-title":"Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States","volume":"41","author":"Alm","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0181-5512(07)89584-2","article-title":"A new approach for better comprehension of diseases of the ocular surface","volume":"30","author":"Baudouin","year":"2007","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bjo.82.1.39","article-title":"Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers","volume":"82","author":"Baudouin","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0161-6420(94)31322-4","article-title":"Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma","volume":"101","author":"Baudouin","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib5","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","article-title":"Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term","volume":"111","author":"Baudouin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaci.2005.05.033","article-title":"CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1\/T(H)2 in ocular surface disorders","volume":"116","author":"Baudouin","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","article-title":"The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways","volume":"115","author":"Baudouin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib9","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1167\/iovs.07-0266","article-title":"In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost","volume":"48","author":"Baudouin","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1755-3768.2008.01250.x","article-title":"Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma","volume":"86","author":"Baudouin","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1067\/mai.2001.112941","article-title":"Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions","volume":"107","author":"Beasley","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(14)76730-3","article-title":"Conjunctival impression cytology in patients with glaucoma using long-term topical medication","volume":"112","author":"Brandt","year":"1991","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archopht.121.6.892","article-title":"Does benzalkonium chloride cause cataract?","volume":"121","author":"Brandt","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02713680801971857","article-title":"In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line","volume":"33","author":"Brasnu","year":"2008","journal-title":"Curr. Eye. Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib15","first-page":"394","article-title":"Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong\u2013Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines","volume":"14","author":"Brasnu","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.exer.2003.08.005","article-title":"Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies","volume":"78","author":"Brignole-Baudouin","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","article-title":"Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva","volume":"10","author":"Broadway","year":"2001","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib18","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","article-title":"Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile","volume":"112","author":"Broadway","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib19","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","article-title":"Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery","volume":"112","author":"Broadway","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib20","first-page":"668","article-title":"Efficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertension","volume":"26","author":"Bron","year":"2003","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib21","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1167\/iovs.05-1460","article-title":"Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride","volume":"47","author":"Buron","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0420.1997.tb00480.x","article-title":"Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients","volume":"224","author":"Campagna","year":"1997","journal-title":"Acta Ophthalmol. Scand. Suppl."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib23","series-title":"The Preocular Tear Film","article-title":"Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate","author":"Champeau","year":"1986"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ophtha.2005.10.050","article-title":"Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study","volume":"113","author":"Chandrasekaran","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.ico.0000183538.53017.69","article-title":"Are multidose over-the-counter artificial tears adequately preserved?","volume":"25","author":"Charnock","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib26","first-page":"228","article-title":"Conservateurs et pr\u00e9paration ophtalmiques: r\u00e9alit\u00e9s et perspectives","volume":"55","author":"Chibret","year":"1997","journal-title":"Ann. Pharmaceutiques Fran\u00e7aises"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib27","first-page":"415","article-title":"Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin","volume":"12","author":"Chung","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/112067210801800314","article-title":"An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes","volume":"18","author":"Ciancaglini","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"issue":"Suppl 1","key":"10.1016\/j.preteyeres.2010.03.001_bib29","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.survophthal.2003.12.019","article-title":"Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension","volume":"49","author":"Cohen","year":"2004","journal-title":"Surv. Ophthalmol."},{"issue":"Suppl. 2","key":"10.1016\/j.preteyeres.2010.03.001_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/026119290203002S10","article-title":"Ocular safety: a silent (in vitro) success story","volume":"30","author":"Curren","year":"2002","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00184009","article-title":"Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma","volume":"232","author":"de Jong","year":"1994","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.exer.2003.10.006","article-title":"Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong\u2013Kilbourne derivative of Chang conjunctival cell line","volume":"78","author":"De Saint Jean","year":"2004","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib33","first-page":"619","article-title":"Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells","volume":"40","author":"De Saint Jean","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0271-3683(200002)2021-DFT085","article-title":"Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells","volume":"20","author":"De Saint Jean","year":"2000","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib35","first-page":"642","article-title":"Quaternary ammoniums and other preservatives\u2019 contribution in oxidative stress and apoptosis on Chang conjunctival cells","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib37","first-page":"2525","article-title":"Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib36","first-page":"3409","article-title":"Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells","volume":"43","author":"Debbasch","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib38","first-page":"297","article-title":"Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or ocular hypertension","volume":"16","author":"Denis","year":"1993","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib39","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.tiv.2006.07.006","article-title":"In vitro genotoxicity and cytotoxicity of benzalkonium chloride","volume":"20","author":"Deutschle","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib40","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1167\/iovs.03-0560","article-title":"Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva","volume":"44","author":"Diebold","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1442-9071.2003.00760.x","article-title":"Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients","volume":"32","author":"Dogan","year":"2004","journal-title":"Clin. Exper. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/1080768041725326","article-title":"Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits","volume":"20","author":"Dong","year":"2004","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib43","first-page":"273","article-title":"A new in vitro human epithelial model for assessing eye irritating potential of formulated cosmetic products","volume":"11","author":"Doucet","year":"1998","journal-title":"In Vitro Mol. Toxicol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tiv.2005.09.005","article-title":"Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products","volume":"20","author":"Doucet","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Dry Eye WorkShop","year":"2007","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Dry Eye WorkShop","year":"2007","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/bjo.2005.080424","article-title":"Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients","volume":"90","author":"Easty","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jop.2008.0098","article-title":"Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib50","unstructured":"EMEA public statement on antimicrobial preservatives in ophthalmic preparations for human use. EMEA\/622721\/2009, London, 8 December 2009."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib51","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00417-008-0881-9","article-title":"German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye","volume":"246","author":"Erb","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib52","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0161-6420(02)01010-2","article-title":"Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial","volume":"109","author":"Fellman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/mutage\/gem027","article-title":"Benzalkonium chloride (BAC) and dimethyldioctadecyl-ammonium bromide (DDAB), two common quaternary ammonium compounds, cause genotoxic effects in mammalian and plant cells at environmentally relevant concentrations","volume":"22","author":"Ferk","year":"2007","journal-title":"Mutagenesis"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/BF02850204","article-title":"The dilution of benzalkonium chloride (BAK) in the tear film","volume":"23","author":"Friedlaender","year":"2006","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib55","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1021\/ed077p1335","article-title":"Analysis of common household cleaner-disinfectants by capillary elektrophoresis","volume":"77","author":"Gardner","year":"2000","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib56","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ajo.2009.06.018","article-title":"Three-year follow-up of the tube versus trab\u00e9culectomie study","volume":"148","author":"Gedde","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02169786","article-title":"Influence of artificial tears on corneal epithelium in dry-eye syndrome","volume":"227","author":"Gobbels","year":"1989","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib58","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0161-6420(92)31879-2","article-title":"Corneal epithelial permeability of dry eyes before and after treatment with artificial tears","volume":"99","author":"Gobbels","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/archopht.121.6.835","article-title":"Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol","volume":"121","author":"Goto","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/IJG.0b013e31815a3472","article-title":"Duration of IOP reduction with travoprost BAK-free solution","volume":"17","author":"Gross","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib61","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1167\/iovs.05-0776","article-title":"In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells","volume":"46","author":"Guenoun","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib62","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1167\/iovs.04-1331","article-title":"In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells","volume":"46","author":"Guenoun","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-3768.2008.01381.x","article-title":"Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis","volume":"242","author":"Hamacher","year":"2008","journal-title":"Acta Ophthalmol. Suppl. (Oxf)"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib64","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00417-003-0777-7","article-title":"In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells","volume":"241","author":"Hamard","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib65","first-page":"613","article-title":"Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy","volume":"2","author":"Henry","year":"2008","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib66","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajo.2006.06.052","article-title":"Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study","volume":"142","author":"Herman","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib67","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","article-title":"Ocular surface alteration after long-term treatment with an antiglaucomatous drug","volume":"99","author":"Herreras","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/112067210701700108","article-title":"A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%\/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension","volume":"17","author":"Hommer","year":"2007","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2006.02.056","article-title":"Effects of topical antiglaucoma application on conjunctival impression cytology specimens","volume":"142","author":"Hong","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003226-199211030-00006","article-title":"Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride","volume":"11","author":"Ichijima","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib71","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00061198-200312000-00008","article-title":"Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride","volume":"12","author":"Ishibashi","year":"2003","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib72","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12325-008-0078-y","article-title":"Quantitative analysis of conjunctival goblet cells after chronic application of topical drops","volume":"25","author":"Kahook","year":"2008","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib74","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-9-5","article-title":"Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model","volume":"9","author":"Khoh-Reiter","year":"2009","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib76","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2008.144469","article-title":"Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers","volume":"92","author":"Kim","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.79.4.339","article-title":"Effect of timolol with and without preservative on the basal tear turnover in glaucoma","volume":"79","author":"Kuppens","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib78","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.ophtha.2005.05.021","article-title":"In vivo confocal microscopy study of blebs after filtering surgery","volume":"112","author":"Labbe","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib79","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ophtha.2006.03.050","article-title":"Epithelial basement membrane dystrophy: evaluation with the HRT II Rostock Cornea Module","volume":"113","author":"Labbe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jop.2006.22.267","article-title":"Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study","volume":"22","author":"Labbe","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib81","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ophtha.2008.11.021","article-title":"In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis","volume":"116","author":"Labbe","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib82","first-page":"S665","article-title":"Comparison of the efficacy and tolerability of preservative-free 2.0% dorzolamide\/0.5% timolol and 2.0% dorzolamide\/0.5% timolol","volume":"40","author":"Laibovitz","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF02616110","article-title":"Survey of ATCC stocks of human cell lines for HeLa contamination","volume":"14","author":"Lavappa","year":"1978","journal-title":"In Vitro"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib84","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archopht.1990.01070130045027","article-title":"The influence of prior therapy on the success of trabeculectomy","volume":"108","author":"Lavin","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2004.03.006","article-title":"Conjunctival hyperemia associated with bimatoprost use: a histopathologic study","volume":"138","author":"Leal","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib86","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.ijg.0000212274.50229.c6","article-title":"Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy","volume":"16","author":"Lewis","year":"2007","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib88","article-title":"Live conjunctiva-associated lymphoid associated tissue (CALT) analysis in rabbit using in vivo confocal microscopy (IVCM) under inflammatory stimuli","author":"Liang","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib90","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bjo.2008.138768","article-title":"Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride","volume":"92","author":"Liang","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib91","first-page":"204","article-title":"Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits","volume":"14","author":"Liang","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib93","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12325-009-0023-8","article-title":"A randomized clinical comparison of OPTI-FREE EXPRESS and ReNu MultiPLUS multipurpose lens care solutions","volume":"26","author":"Lipener","year":"2009","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2007.08.017","article-title":"Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea","volume":"348","author":"Majumdar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib95","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2008.10.019","article-title":"An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology","volume":"147","author":"Martone","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib96","article-title":"Occludin gene expression as an early in vitro sign for mild eye irritation assessment","author":"Meloni","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib98","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","article-title":"T-cell cytokines in chronic allergic eye disease","volume":"100","author":"Metz","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib99","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0886-3350(03)00560-1","article-title":"ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy","volume":"29","author":"Miyake","year":"2003","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/112067210301300608","article-title":"Impression cytology of the conjunctival epithelium after antiglaucomatous treatment with latanoprost","volume":"13","author":"Moreno","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib101","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02849799","article-title":"Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes","volume":"20","author":"Mundorf","year":"2003","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib102","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/archopht.1983.01040020871007","article-title":"Cellulose acetate impressions of the ocular surface. Dry eye states","volume":"101","author":"Nelson","year":"1983","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib103","series-title":"Alternative Toxicological Methods","first-page":"147","author":"Nguyen","year":"2003"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib104","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","article-title":"Vision related quality of life and topical glaucoma treatment side effects","volume":"1","author":"Nordmann","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1006051725115","article-title":"Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response","volume":"22","author":"Nuzzi","year":"1998","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib107","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00166608","article-title":"Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study","volume":"233","author":"Nuzzi","year":"1995","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib108","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.eye.6701441","article-title":"Alphagan allergy may increase the propensity for multiple eye-drop allergy","volume":"19","author":"Osborne","year":"2005","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevOncog.v11.i34.30","article-title":"Benzalkonium salts: effects on G protein-mediated processes and surface membranes","volume":"11","author":"Patarca","year":"2000","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejps.2008.04.006","article-title":"In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride","volume":"34","author":"Pauloin","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib111","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00417-006-0353-z","article-title":"Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles","volume":"245","author":"Pauly","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib112","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.06-0728","article-title":"New tools for the evaluation of toxic ocular surface changes in the rat","volume":"48","author":"Pauly","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib113","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/02713680802381460","article-title":"In vivo confocal microscopic grading system for standardized corneal evaluation: application to toxic-induced damage in rat","volume":"33","author":"Pauly","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib114","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib115","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1208\/pt070113","article-title":"Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas","volume":"7","author":"Pawar","year":"2006","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib116","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000192082","article-title":"Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost","volume":"41","author":"Pellinen","year":"2009","journal-title":"Ophthalmic. Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib117","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1167\/iovs.03-1067","article-title":"Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study","volume":"45","author":"Pisella","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000055579","article-title":"Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits","volume":"32","author":"Pisella","year":"2000","journal-title":"Ophthalmic. Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib119","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1208\/pt070357","article-title":"Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops","volume":"7","author":"Rathore","year":"2006","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib121","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/IJG.0b013e31818153f4","article-title":"Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment","volume":"18","author":"Rodrigues Mde","year":"2009","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib122","series-title":"The Lacrimal System","article-title":"The effect of different benzalkonium chloride concentrations on human normal ocular surface","author":"Rolando","year":"1991"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib123","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1464-410X.2003.03081.x","article-title":"Effects of benzalkonium chloride treatment on the intramural innervation of the upper urinary tract","volume":"91","author":"Rolle","year":"2003","journal-title":"BJU Int."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib124","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/jop.2006.22.440","article-title":"Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system","volume":"22","author":"Rosenthal","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":"Dry eye syndrome-related quality of life in glaucoma patients","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4835(89)90071-7","article-title":"The effect of epinephrine and benzalkonium chloride on cultured corneal endothelial and trabecular meshwork cells","volume":"49","author":"Samples","year":"1989","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0161-6420(92)32001-9","article-title":"Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications","volume":"99","author":"Schwab","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","article-title":"Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon\u2019s capsule in glaucomatous patients","volume":"96","author":"Sherwood","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib129","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bjo.2006.094912","article-title":"Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?","volume":"90","author":"Souchier","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib130","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0002-9394(44)90120-0","article-title":"Reactivity of the ocular tissues to wetting agents","volume":"27","author":"Swan","year":"1944","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib131","first-page":"162","article-title":"Microbial contamination of eye drops","volume":"9","author":"Tasli","year":"2001","journal-title":"Cent. Eur. J. Public Health"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib132","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2008-1045518","article-title":"The COMOD system. A preservative-free multidose container for eyedrops","volume":"205","author":"Teping","year":"1994","journal-title":"Klin. Monbl. Augenheilkd"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib133","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bjo.2008.140186","article-title":"Effect of latanoprost and timolol on the histopathology of the human conjunctiva","volume":"93","author":"Terai","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","article-title":"Mucous membrane pemphigoid and pseudopemphigoid","volume":"111","author":"Thorne","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0536.2008.01327.x","article-title":"Is the irritant benzalkonium chloride a contact allergen? A contribution to the ongoing debate from a clinical perspective","volume":"58","author":"Uter","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1755-3768.2008.01380.x","article-title":"Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers","volume":"242","author":"Uusitalo","year":"2008","journal-title":"Acta Ophthalmol. Suppl. (Oxf)"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib137","unstructured":"Uusitalo, H., Chen, E., Pfeiffer, N., Brignole-Baudouin, F., Kaarniranta, K., Leino, M., et\u00a0al. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol., in press."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib138","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials","volume":"112","author":"van der Valk","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2010.03.001_bib139","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.59.11.667","article-title":"Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man","volume":"59","author":"Wilson","year":"1975","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib141","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0420.1995.tb00277.x","article-title":"Effects of antiglaucoma drugs on ocular surface","volume":"73","author":"Yalvac","year":"1995","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib142","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2008.04.002","article-title":"Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea","volume":"87","author":"Yenice","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib143","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1167\/iovs.07-0984","article-title":"Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues","volume":"49","author":"Yu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2010.03.001_bib144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/jop.2008.0072","article-title":"The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence","volume":"25","author":"Zimmerman","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946210000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946210000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:03:51Z","timestamp":1739959431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946210000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1350946210000157"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2010.03.001","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}